Joost Peerbooms

14 Chapter 1 REFERENCES 1. Björklund L. The Bone and Joint Decade 2000–2010. Inaugural Meeting 17 and 18 April 1998, Lund, Sweden. Acta Orthop Scand. 1998; 281: 67–80. 2. Andres B, Murrell G. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res. 2008; 466(7): 1539-54. 3. Mehallo C, Drezner J, Bytomski J. Practical Management: Nonsteroidal Anti-inflammatory Drug (NSAID) use in Athletic Injuries. Clin J Sport Med. 2006; 16(2): 170-4. 4. Anitua E, Cugat R, Sánchez M. Platelet Rich Plasma in Orthopaedics and Sports Medicine. Springer 2018: 277-83. ISBN 9783319637297. 5. Marx R, Carlson E, Eichstaedt R et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 1998; 85: 638–46. 6. Wasterlain A, Braun H, Dragoo J. Contents and formulations of platelet-rich plasma. Operative Techniques in Orthopaedics. 2012; 22(1): 33–42. 7. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 2008; 1 (3-4): 165-74. 8. Alsousou J, Thompson M, Hulley P, et al. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg [Br]. 2009; 91: 987-96. 9. Foster TE, Puskas B, Mandelbaum B, et al. Platelet-Rich Plasma. From Basic Science to Clinical Applications. Am J Sports Med. 2009; 37: 2259-72. 10. Kingsley C. Blood coagulation: evidence of an antagonist to factor VI in platelet-rich human plasma. Nature. 1954; 173: 723–24. 11. Matras, H. Effect of various fibrin preparations on reimplantations in the rat skin. Osterreichische Z Stomatol. 1970; 67: 338–59. 12. Knighton D, Ciresi K, Fiegel V, et al. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg. 1986; 204: 322–30. 13. Kushida S, Kakudo N, Morimoto N, et al. Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. J Artif Organs. 2014; 17(2): 186-92. 14. Weibrich G, Kleis W, Hafner G, et al. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg. 2002; 30: 97–102. 15. Lansdown D, Fortier L. Platelet-Rich Plasma: Formulations, Preparations, Constituents, and Their Effects. Oper Tech Sports Med. 2017; 25: 7–12. 16. Harrison S, Vavken P, Kevy S et al. Platelet Activation by Collagen Provides Sustained Release of Anabolic Cytokines. Am J Sports Med. 2011; 39(4): 729–34. 17. Chen X, Jones I, Park C, et al. The Efficacy of Platelet-Rich Plasma on Tendon and Ligament Healing. A Systematic Review and Meta-analysis With Bias Assessment. Am J Sports Med. 2018; 46(8): 2020-32.